
Amivantamab/Lazertinib Shows OS and PFS Benefits in EGFR-Mutated NSCLC
Xiuning Le, MD, PhD Associate Professor, Department of Thoracic/Head and Neck Medical Oncology Division of Internal Medicine The University of Texas MD Anderson Cancer Center Houston, TX Targeted Oncology: What were the outcomes of the MARIPOSA trial ( …